CTA
EGRX

Carillon Tower Advisers’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Carillon Tower Advisers’s Portfolio EGRX Stock Details EGRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$3.36M Sell
2020
Q3 		$3.22M Buy
2020
Q2 		$2.41M Sell
2020
Q1 		$2.37M Sell
2019
Q4 		$3.42M Sell
2019
Q3 		$3.33M Sell
2019
Q2 		$3.31M Buy
2019
Q1 		$2.7M Buy
2018
Q4 		$2.14M Buy
2018
Q3 		$2.95M Buy